Psychological Impact of <i>TP53</i>-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance Cohort

Counselling and genetic testing (CGT) after neonatal screening may increase depression and anxiety (DA) levels during cancer surveillance. This study assessed the DA scores in mothers of newborns from Paraná state, Southern Brazil, carrying the <i>TP53</i> p.R337H variant. To understand...

Full description

Bibliographic Details
Main Authors: Amanda Scartezini Gozdziejewski, Clarice Wichinescki Zotti, Isabela Aparecida Moreira de Carvalho, Thairine Camargo dos Santos, Luana Rayana de Santi Walter, Karin Rosa Persegona Ogradowski, Karin Luiza Dammski, Heloisa Komechen, Monalisa Castilho Mendes, Emanuelle Nunes de Souza, Mariana Martins Paraizo, Ivy Zortea da Silva Parise, Guilherme Augusto Parise, André Luiz Grion, Gislaine Custódio, Rosiane Guetter Mello, Bonald C. Figueiredo
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/12/2945
_version_ 1797489113535873024
author Amanda Scartezini Gozdziejewski
Clarice Wichinescki Zotti
Isabela Aparecida Moreira de Carvalho
Thairine Camargo dos Santos
Luana Rayana de Santi Walter
Karin Rosa Persegona Ogradowski
Karin Luiza Dammski
Heloisa Komechen
Monalisa Castilho Mendes
Emanuelle Nunes de Souza
Mariana Martins Paraizo
Ivy Zortea da Silva Parise
Guilherme Augusto Parise
André Luiz Grion
Gislaine Custódio
Rosiane Guetter Mello
Bonald C. Figueiredo
author_facet Amanda Scartezini Gozdziejewski
Clarice Wichinescki Zotti
Isabela Aparecida Moreira de Carvalho
Thairine Camargo dos Santos
Luana Rayana de Santi Walter
Karin Rosa Persegona Ogradowski
Karin Luiza Dammski
Heloisa Komechen
Monalisa Castilho Mendes
Emanuelle Nunes de Souza
Mariana Martins Paraizo
Ivy Zortea da Silva Parise
Guilherme Augusto Parise
André Luiz Grion
Gislaine Custódio
Rosiane Guetter Mello
Bonald C. Figueiredo
author_sort Amanda Scartezini Gozdziejewski
collection DOAJ
description Counselling and genetic testing (CGT) after neonatal screening may increase depression and anxiety (DA) levels during cancer surveillance. This study assessed the DA scores in mothers of newborns from Paraná state, Southern Brazil, carrying the <i>TP53</i> p.R337H variant. To understand and adjust DA conditions during term of pregnancy, we initially detected sociodemographic covariates [marital status (MS), number of children (NC), and/or education level (EL): MS-NC-EL] on an independent group of pregnant women (not subjected to genetic testing). The Hospital Anxiety and Depression Scale (HADS) was used to assess risk factors in pregnant (cross-sectional analysis) and unrelated mothers (at 2-month intervals, longitudinal study) of <i>TP53</i> p.R337H-tested newborns (three sessions of HADS analysis) using Wilcoxon (Mann–Whitney) and Kruskal–Wallis nonparametric tests. Lower anxiety levels were observed in mothers of noncarriers (without MS-NC-EL = 6.91 ± 1.19; with MS-NC-EL = 6.82 ± 0.93) than in mothers of p.R337H carriers in the first session (without MS-NC-EL = 6.82 = 8.49 ± 0.6025, with MS-NC-EL = 6.82 = 9.21 ± 0.66). The anxiety levels significantly decreased 4 months after CGT (third session) in mothers of p.R337H carriers. We did not find a significant change in depression scores. Mothers with mental health instability requiring medications need periodical psychological support during and after CGT.
first_indexed 2024-03-10T00:12:51Z
format Article
id doaj.art-2fe922f67d474663a234f3926e6d02cc
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T00:12:51Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-2fe922f67d474663a234f3926e6d02cc2023-11-23T15:56:53ZengMDPI AGCancers2072-66942022-06-011412294510.3390/cancers14122945Psychological Impact of <i>TP53</i>-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance CohortAmanda Scartezini Gozdziejewski0Clarice Wichinescki Zotti1Isabela Aparecida Moreira de Carvalho2Thairine Camargo dos Santos3Luana Rayana de Santi Walter4Karin Rosa Persegona Ogradowski5Karin Luiza Dammski6Heloisa Komechen7Monalisa Castilho Mendes8Emanuelle Nunes de Souza9Mariana Martins Paraizo10Ivy Zortea da Silva Parise11Guilherme Augusto Parise12André Luiz Grion13Gislaine Custódio14Rosiane Guetter Mello15Bonald C. Figueiredo16Pelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilFaculdades Pequeno Príncipe, 333 Iguaçu Av., Rebouças, Curitiba 80230-902, PR, BrazilFaculdades Pequeno Príncipe, 333 Iguaçu Av., Rebouças, Curitiba 80230-902, PR, BrazilFaculdades Pequeno Príncipe, 333 Iguaçu Av., Rebouças, Curitiba 80230-902, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilCentro de Genética Molecular e Pesquisa do Câncer em Crianças (CEGEMPAC), UFPR, 400 Agostinho Leão Jr. Av., Curitiba 80030-110, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, BrazilCounselling and genetic testing (CGT) after neonatal screening may increase depression and anxiety (DA) levels during cancer surveillance. This study assessed the DA scores in mothers of newborns from Paraná state, Southern Brazil, carrying the <i>TP53</i> p.R337H variant. To understand and adjust DA conditions during term of pregnancy, we initially detected sociodemographic covariates [marital status (MS), number of children (NC), and/or education level (EL): MS-NC-EL] on an independent group of pregnant women (not subjected to genetic testing). The Hospital Anxiety and Depression Scale (HADS) was used to assess risk factors in pregnant (cross-sectional analysis) and unrelated mothers (at 2-month intervals, longitudinal study) of <i>TP53</i> p.R337H-tested newborns (three sessions of HADS analysis) using Wilcoxon (Mann–Whitney) and Kruskal–Wallis nonparametric tests. Lower anxiety levels were observed in mothers of noncarriers (without MS-NC-EL = 6.91 ± 1.19; with MS-NC-EL = 6.82 ± 0.93) than in mothers of p.R337H carriers in the first session (without MS-NC-EL = 6.82 = 8.49 ± 0.6025, with MS-NC-EL = 6.82 = 9.21 ± 0.66). The anxiety levels significantly decreased 4 months after CGT (third session) in mothers of p.R337H carriers. We did not find a significant change in depression scores. Mothers with mental health instability requiring medications need periodical psychological support during and after CGT.https://www.mdpi.com/2072-6694/14/12/2945<i>TP53</i> p.R337H mutationpredictive testinggenetic counsellinganxietydepression
spellingShingle Amanda Scartezini Gozdziejewski
Clarice Wichinescki Zotti
Isabela Aparecida Moreira de Carvalho
Thairine Camargo dos Santos
Luana Rayana de Santi Walter
Karin Rosa Persegona Ogradowski
Karin Luiza Dammski
Heloisa Komechen
Monalisa Castilho Mendes
Emanuelle Nunes de Souza
Mariana Martins Paraizo
Ivy Zortea da Silva Parise
Guilherme Augusto Parise
André Luiz Grion
Gislaine Custódio
Rosiane Guetter Mello
Bonald C. Figueiredo
Psychological Impact of <i>TP53</i>-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance Cohort
Cancers
<i>TP53</i> p.R337H mutation
predictive testing
genetic counselling
anxiety
depression
title Psychological Impact of <i>TP53</i>-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance Cohort
title_full Psychological Impact of <i>TP53</i>-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance Cohort
title_fullStr Psychological Impact of <i>TP53</i>-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance Cohort
title_full_unstemmed Psychological Impact of <i>TP53</i>-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance Cohort
title_short Psychological Impact of <i>TP53</i>-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance Cohort
title_sort psychological impact of i tp53 i variant carrier newborns and counselling on mothers a pediatric surveillance cohort
topic <i>TP53</i> p.R337H mutation
predictive testing
genetic counselling
anxiety
depression
url https://www.mdpi.com/2072-6694/14/12/2945
work_keys_str_mv AT amandascartezinigozdziejewski psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT claricewichinesckizotti psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT isabelaaparecidamoreiradecarvalho psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT thairinecamargodossantos psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT luanarayanadesantiwalter psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT karinrosapersegonaogradowski psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT karinluizadammski psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT heloisakomechen psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT monalisacastilhomendes psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT emanuellenunesdesouza psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT marianamartinsparaizo psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT ivyzorteadasilvaparise psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT guilhermeaugustoparise psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT andreluizgrion psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT gislainecustodio psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT rosianeguettermello psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort
AT bonaldcfigueiredo psychologicalimpactofitp53ivariantcarriernewbornsandcounsellingonmothersapediatricsurveillancecohort